Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-16

Clinical Trial Update: Efficacy of Stromal Vascular Fraction Versus Platelet Rich Plasma in Treatment of Androgenitic Alopecia [NA]

View source ↗

Summary

A clinical trial assessing stromal vascular fraction versus platelet-rich plasma for androgenetic alopecia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-rich plasma (platelet-rich plasma)
  • Stromal Vascular Fraction (stromal vascular fraction)

Snippet

Sponsor: Kasr El Aini Hospital | Conditions: Androgenetic Alopecia | NA | Status: NOT_YET_RECRUITING